key: cord-0293622-eyhgtpe0
authors: Brusaferri, L.; Alshelh, Z.; Martins, D.; Kim, M.; Weerasekera, A.; Housman, H.; Morrisey, E. J.; Knight, P. C.; Castro-Blanco, K. A.; Albrecht, D. S.; Tseng, C.-E.; Zurcher, N. R.; Ratai, E.-M.; Johnson-Akeju, O.; Mercaldo, N. D.; Hadjikhani, N.; Veronese, M.; Turkheimer, F.; Rosen, B. R.; Hooker, J. M.; Loggia, M. L.
title: The Pandemic Brain: neuroinflammation in healthy, non-infected individuals during the COVID-19 pandemic
date: 2021-09-27
journal: nan
DOI: 10.1101/2021.09.21.21263740
sha: f8ffa1de6d52f25fe8bd7b3fa88b4bae74d6eb6a
doc_id: 293622
cord_uid: eyhgtpe0

The impact of COVID-19 on human health extends beyond the morbidity and death toll directly caused by the SARS-CoV-2 virus. In fact, accumulating evidence indicates a global increase in the incidence of fatigue, brain fog and depression, including among non-infected, since the pandemic onset. Motivated by previous evidence linking those symptoms to neuroimmune activation in other pathological contexts, we hypothesized that subjects examined after the enforcement of lockdown/stay-at-home measures would demonstrate increased neuroinflammation. We performed simultaneous brain Positron Emission Tomography / Magnetic Resonance Imaging in healthy volunteers either before (n=57) or after (n=15) the 2020 Massachusetts lockdown, using [11C]PBR28, a radioligand for the glial marker 18 kDa translocator protein (TSPO). First, we compared [11C]PBR28 signal across pre- and post-lockdown cohorts. Then, we evaluated the link between neuroinflammatory signals and scores on a questionnaire assessing mental and physical impacts of the pandemic. Further, we investigated multivariate associations between the spatial pattern of [11C]PBR28 post-lockdown changes and constitutive brain gene expression in post-mortem brains (Allen Human Brain Atlas). Finally, in a subset (n=13 pre-lockdown; n=11 post-lockdown), we also used magnetic resonance spectroscopy to quantify brain (thalamic) levels of myoinositol (mIns), another neuroinflammatory marker. Both [11C]PBR28 and mIns signals were overall stable pre-lockdown, but markedly elevated after lockdown, including within brain regions previously implicated in stress, depression and 'sickness behaviors'. Moreover, amongst the post-lockdown cohort, subjects endorsing higher symptom burden showed higher [11C]PBR28 PET signal compared to those reporting little/no symptoms. Finally, the post-lockdown [11C]PBR28 signal changes were spatially aligned with the constitutive expression of several genes highly expressed in glial/immune cells and/or involved in neuroimmune signaling. Our results suggest that pandemic-related stressors may have induced sterile neuroinflammation in healthy individuals that were not infected with SARS-CoV-2. This work highlights the possible impact of the COVID-19 pandemic-related lifestyle disruptions on human brain health.

The impact of COVID-19 on human health extends beyond the morbidity and death toll directly caused by the SARS-CoV-2 virus. In fact, accumulating evidence indicates a global increase in the incidence of fatigue, brain fog and depression, including among non-infected, since the pandemic onset. Motivated by previous evidence linking those symptoms to neuroimmune activation in other pathological contexts, we hypothesized that subjects examined after the enforcement of lockdown/stay-at-home measures would demonstrate increased neuroinflammation.

We performed simultaneous brain Positron Emission Tomography / Magnetic Resonance Imaging in healthy volunteers either before (n=57) or after (n=15) the 2020 Massachusetts lockdown, using [ 11 C]PBR28, a radioligand for the glial marker 18 kDa translocator protein (TSPO). First, we compared [ 11 C]PBR28 signal across pre-and post-lockdown cohorts. Then, we evaluated the link between neuroinflammatory signals and scores on a questionnaire assessing mental and physical impacts of the pandemic. Further, we investigated multivariate associations between the spatial pattern of [ 11 C]PBR28 post-lockdown changes and constitutive brain gene expression in post-mortem brains (Allen Human Brain Atlas). Finally, in a subset (n=13 prelockdown; n=11 post-lockdown), we also used magnetic resonance spectroscopy to quantify brain (thalamic) levels of myoinositol (mIns), another neuroinflammatory marker.

Beyond the staggering number of infections and deaths, the Coronavirus Disease 2019 pandemic has caused lifestyle, societal, and other disruptions, impacting the lives of a large swath of the world population in multiple ways. For instance, behavioral data have shown that symptoms of psychological distress have increased considerably in the United States since the enforcement of lockdown/stay-at-home measures (e.g., April-June of 2020, compared to the same period in 2019) 1 . Likewise, an increased prevalence of fatigue, dyscognition (i.e., "brain fog") and other symptoms has been reported (including among the non-infected). As such, the scientific and medical communities are urgently calling for studies promoting a better understanding of the effects of the pandemic on brain and mental health. [2] [3] [4] While the mechanisms underlying the non-virally mediated effects of the COVID-19 pandemic on brain health are currently unknown, we hypothesized that an elevation in neuroinflammatory responses might play a role. In fact, exposure to social stressors, including social isolation (a state experienced by many during lockdown), has been previously linked to elevations in serum levels of pro-inflammatory cytokines 5 and activation of brain glial cells, 6, 7 involving mechanisms largely overlapping with those observed during infection-induced inflammation. 8 Such "sterile" forms of (neuro)inflammation -much like their pathogen-associated counterparts-have been linked to produce a constellation of "sickness behaviors", including fatigue, depressive symptoms, social withdrawal, etc. 9,10 Indeed, sterile-(neuro)inflammation is thought to be a key neurobiological process in the pathophysiology of mood disorders. [11] [12] [13] Notably, elevations in (neuro)inflammatory markers have also been measured in patients suffering from fibromyalgia, 14 myalgic encephalomyelitis / chronic fatigue syndrome, 15 Gulf War Illness 16 or insomnia. 17 These conditions are characterized by abnormal fatigue, brain fog and/or other psychological symptoms which have been increasingly documented during the pandemic. Thus, results from both clinical and preclinical literature raise the possibility that neuroinflammation might be a potential mechanism underlying the symptoms experienced during the pandemic by healthy individuals that were not infected by SARS-CoV-2.

To test this hypothesis, we conducted a retrospective analysis of advanced, multimodal we hypothesized that, after lockdown, subjects would demonstrate increased brain levels of the 18 kDa translocator protein (TSPO), 18 and myoinositol (mIns), 19 two putative glial markers that can be detected with PET and MR spectroscopy, respectively. In order to assess the clinical significance of our findings, we performed a preliminary investigation of the link between neuroinflammatory signals and scores on a questionnaire assessing mental and physical impacts of the pandemic. Finally, to understand the genetic underpinnings of our imaging results, we evaluated their spatial association with constitutive brain gene expression in post-mortem brains (Allen Human Brain Atlas). 20

This research study was conducted at the Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital. Data were pooled for several protocols, which were approved by the Partners Healthcare / Mass General Brigham Institutional Review Board. All participants gave written informed consent at the time of their screening.

We conducted a retrospective brain imaging study of healthy individuals, originally enrolled as control subjects for various completed or ongoing, research studies investigating the role of neuroinflammation in various disorders.

In total, this study included fifty-seven 'pre-lockdown' datasets (HCPRE, acquired between 04/2012 and 02/2020) and fifteen 'post-lockdown' datasets (HCPOST, acquired between 08/2020 and 07/2021) (Suppl. Figure 1 ). For twenty-two subjects included in the HCPRE group, a second dataset was available, which was used in this study for support/sensitivity analyses (see Appendix).

Of note, two participants were scanned before and after lockdown, thus contributing to data in both HCPRE and HCPOST groups; of those, one subject was scanned before (September 2016) and after (October 2020) lockdown in the same scanner (Scanner 1), allowing us for an exploratory investigation of pre-vs post-lockdown within-subject effects.

All subjects in the HCPOST cohort had a negative COVID-19 antibody test (Elecsys® Anti-SARS-CoV-2, Roche Diagnostics; 99.81% accuracy; 95% confidence interval (CI): 99.65-99.1) at the time of the scan. No COVID-19 antibody testing was available for any of the HCPRE participants.

Demographics for the participants used in the PET and 1 H-MRS analyses are displayed in Tables 1 and 2, respectively. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 27, 2021. ;

During an initial screening visit, participants were consented, and genotyped for the Ala147Thr polymorphism in the TSPO gene, which is known to affect binding affinity for several TSPO radioligands, including [ 11 C]PBR28. 21 Individuals with the Ala/Ala or Ala/Thr genotypes (predicted high-and mixed-affinity binders -HABs and MABs-, respectively) were included, and the genotype was modeled as a covariate in the statistical design (see below). Individuals with the Thr/Thr genotype (predicted "low-affinity binders") were excluded at the time of the screening and therefore not represented in our dataset.

Dynamic PET/MR scans were performed with two different Siemens scanners: a 3T Tim Trio whole-body MRI with a dedicated brain PET insert (BrainPET; Scanner 1) and a 3T Verio whole-body, MRI whole-body PET tomograph (Biograph mMR; Scanner 2). Participants were injected with up to ~15 millicuries (mCi) [ 11 C]PBR28 as an intravenous bolus and dynamic PET was acquired as described in previous studies. 12,16 [ 11 C]PBR28 is a second-generation radioligand commonly used to image the glial marker TSPO for the study of neuroinflammation in various conditions. 22 All participants were scanned for a time-period that included ~60-90 minutes postinjection (the framing window used in our PET analyses; see below). See Appendix for further details on PET data acquisition and processing.

SUV ratio (SUVR) images were obtained via intensity-normalization using the occipital cortex as a pseudo-reference region, as done in previous research. 14, 16 This region demonstrated no statistically significant group differences in mean SUV (p=0.18; GLM, correcting for age, scanner and genotype; see below), indicating that the use of this signal as a normalizing factor did not bias our results. To support findings from SUVR measurements, distribution volume (DVR) outcomes were determined using kinetic modeling in a subset of subjects for whom a . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 27, 2021. ;  radiometabolite-corrected arterial input function was available (n=24; 16 HCPRE; 8 HCPOST), as described in the Appendix.

Simultaneously to the PET data collection, a subset (13 HCPRE; 11 HCPOST) was also scanned with 1 H-MRS. Single voxel 1 H-MRS was acquired from the left thalamus using a PRESS sequence with same parameters in both scanners (TE=30ms, TR=1.7s, bandwidth=1.2 kHz, number of averages = 128, sample points = 1024). See Appendix for further details on 1 H-MRS data acquisition and processing. This technique allowed us to quantify the brain concentration of myoinositol (mIns), another putative glial marker, 19 and -for reference-Creatine (Cr; a cellular energetic marker) and N-Acetyl Aspartate (NAA; a marker of neuronal integrity).

To interrogate the possible clinical significance of our results, we retrospectively administered a questionnaire assessing the impact of the COVID-19 pandemic on mental and physical well-being, specifically assessing mental/physical fatigue, dyscognition and mood alterations (n=11; See Appendix).

Descriptive summaries were computed by group (HCPRE, HCPOST). Continuous variables were summarized as mean and standard deviation (SD) and categorical variables were summarized as frequencies and percentages. Group differences in demographics were assessed with Student's t-tests for continuous variables (age, injected dose, weight) and Chi-Square ( ! ) tests for categorical variables (sex, TSPO polymorphism, scanner).

Covariate imbalance was assessed in all the analyses by adjusting for confounding variables but was also accounted for via matching (see Appendix). Specifically, given the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 27, 2021. ; https://doi.org/10.1101/2021.09.21.21263740 doi: medRxiv preprint significant difference in age across HCPRE and HCPOST groups (Tables 1 and 2) , we re-ran all group analyses using smaller subsets of HCPRE who were better demographically matched to the HCPOST cohort (p's≥0.11) (Suppl. Table 1 and 2).

Two sets of analyses were preformed to quantify the association between [ 11 C]PBR28 signal and group. First, pre-and post-lockdown [ 11 C]PBR28 signal was compared in a-priori region-of-interest (ROI) analysis, in areas previously associated with stress or depression: nucleus accumbens, 23 hippocampus, 7,24 thalamus, 25 and anterior cingulate cortex (ACC). 12 Labels from the Harvard-Oxford Cortical and Subcortical Structural Atlas (Center for Morphometric Analyses, http://www.cma.mgh.harvard.edu/fsl_atlas.html) were used to determine these ROIs. For each ROI, a General Linear Model (GLM) was used to quantify the association between PET signal and group while adjusting for age, TSPO binding affinity, and scanner.

Second, we performed a non-parametric voxel-wise analysis of the whole brain to evaluate the presence of group differences in the [ 11 C]PBR28 signal beyond the constraint of our a priori ROIs. Group differences were assessed by using a permutation test (FSL randomise; 5000 permutations; cluster-forming threshold of p=0.01; cluster size threshold of p=0.05), again accounting for age, binding affinity, and scanner. Mindful of the relatively small sample size of the HCPOST cohort, we repeated this analysis with a more conservative cluster-forming threshold of p=0.001, to further reduce the likelihood of false positives. The resulting significant cluster (see Results) was parcellated by intersecting it with anatomical labels in standard space. From these parcels, the mean PET signal was extracted for visualization purposes, as well as correlational and support/sensitivity analyses (see below and Appendix).

In order to assess the link between neuroinflammation and clinical variables, we used GLM analyses to test for differences in [ 11 C]PBR28 signal between HCPOST subjects reporting higher vs . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 27, 2021. ; https://doi.org/10.1101/2021.09.21.21263740 doi: medRxiv preprint lower symptom burden (mental/physical fatigue, dyscognition and mood alteration; see Appendix). These analyses were done using mean signal extracted from the cluster parcels obtained from the main analysis (Bonferroni-corrected for number of regions). Due to the smaller sample size of subjects completing the questionnaire (n=11), the main model employed in these analyses included only TSPO genotype as a covariate.

To further corroborate the hypothesis that increased [ 11 C]PBR28 signal might reflect glial/neuroimmune activity, we performed imaging transcriptomics analyses of the statistical maps quantifying differences between HCPRE and HCPOST cohorts. Specifically, given the spatial heterogeneity in the density of key players in the neuroimmune response across brain regions, we reasoned that if [ 11 C]PBR28 reflect global engagement of glial neuroinflammatory pathways, then regional vulnerability to [ 11 C]PBR28 increases between HCPRE and HCPOST cohorts should follow the constitutive architecture of the neuroinflammatory machinery. Thus, genes positively correlated with [ 11 C]PBR28 changes across brain regions must be enriched for: 1) genes from biological pathways related to neuroimmune pathways and 2) genes highly expressed in microglia/astrocyte cells as key players of the neuroimmune response.

The Allen Human Brain Atlas (AHBA) was used to estimate whole-transcriptome gene expression in the 83 cortical and subcortical regions of the Desikan-Killiany (DK) atlas (Suppl. Finally, we tested the list of genes ranked by the respective weights in PLS1 component for enrichment in genes from specific biological pathways and expressed in different brain cell types.

See Appendix for further details on transcriptomic analysis.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 27, 2021. ;  Finally, to assess the effect of the pandemic on a different putative neuroinflammation imaging marker, we analyzed 1 H-MRS data using GLM to test for group differences in mIns while accounting for age and scanner as regressors of no interest. Group analyses were also conducted on the markers Cr and NAA, for reference.

Voxel-wise analyses were performed with FSL's FEAT GLM tool (www.fmrib.ox.ac.uk/fsl, version 5.0.10). Demographics, ROI PET and behavioral analyses were performed using Statistica (TIBCO Software Inc., v.13). Transcriptomic analyses were conducted using the Web-based gene set analysis toolkit (WebGestalt).

The funder had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.

Post-lockdown participants reported experiencing various symptoms since the onset of the pandemic, including mood alterations (54%), mental (36%) and physical (27%) fatigue, and dyscognition (18%). These symptoms were paralleled by a post-lockdown increase in [ 11 C]PBR28 signal, which was apparent in both ROI and voxelwise analyses (including in all support/sensitivity analyses performed).

The a priori ROI analyses ( Figure 1 ) revealed that [ 11 C]PBR28 signal was higher in HCPOST compared to HCPRE in all the ROI evaluated (p's < 0.05 corrected). Whole-brain voxelwise . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure 5A , Figure 5B ), followed by a noticeable increase after lockdown.

When categorizing the HCPOST subjects into higher and lower symptom burden, we found the PET signal in the IPS and precuneus to be associated with physical fatigue (p<0.01 and p<0.05 uncorrected, respectively), whereas the hippocampal PET signal was more closely linked to mental fatigue and mood alterations (p<0.01 and p<0.05 uncorrected, respectively) (see Figure 5 ). Of these results, the IPS-physical fatigue association remained statistically significant after correction . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 27, 2021. ; https://doi.org/10.1101/2021.09.21.21263740 doi: medRxiv preprint for multiple comparisons. No association was found with dyscognition symptoms (although the very small sample size of participants reporting an increase in this symptom, n=2, rendered this analysis inconclusive).

Regional vulnerability to changes in [ 11 C]PBR28 signal between HCPRE and HCPOST was predicted by regional variability in the human brain transcriptome: PLS1 alone explained 37.33% of variance in [ 11 C]PBR28 T-statistics (Suppl. Figure 10 ) and did so above chance (pSPATIAL < 0.01; see Appendix for details). As Figure 6A illustrates, PLS1 regional scores correlated positively Table 4 ).

Paralleling the [ 11 C]PBR28 PET results, the subset of HCPOST cohort with 1 H-MRS data also demonstrated significantly higher thalamic concentration of the glial metabolite mIns, measured using 1 H-MRS, compared to the HCPRE cohort (p<0.01); Figure 7A ), particularly in the first months post-lockdown ( Figure 7B ). The post-lockdown increases in mIns concentration appeared to be metabolite-specific, since group differences in Cr (a cellular energetic marker) and NAA (a marker of neuronal integrity) concentrations were not statistically significant (p>0.2) (Suppl. Figure 7) . No significant correlation was found between thalamic mIns and SUVR signal (p=0.31).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Figure 6A , Figure 8A ); 2) using alternate datasets (i.e., datasets collected in individuals scanned twice and not used in the primary analyses; Appendix, Suppl. Figure 6B , Figure 8B ); or 3) excluding subjects who had received the vaccine against the SARS-CoV-2 virus (Appendix, Suppl. Figure 6C, Figure 8C )..

This study provides novel evidence of elevated neuroinflammatory markers in healthy,

other states) starting March 2020. HCPOST subjects showed elevations in the brain levels of Further, the regional variability in increased [ 11 C]PBR28 signal could be predicted by constitutive expression of genes related to glial neuroimmune response in healthy post-mortem human brains.

Overall, our results indicate that pandemic-associated stressors may have triggered a neuroimmune response in non-infected individuals.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Although several studies have recently raised the urgent need for research to quantitatively address consequences of COVID-19-related disruptions on human health, 2,3 neuroinflammatory responses in non-infected individuals during the pandemic so far have not been explored.

However, a wealth of pre-clinical studies has shown that inflammatory processes and social behaviors are deeply connected: as inflammatory processes can affect social behaviors, exposure to chronic stressors can also upregulate inflammation. 26 Specifically, prolonged stress can lead to an increase in pro-inflammatory cytokines (e.g., Interleukin-6), 5,27 which in turn may trigger sickness and depressive-like behaviors. 9 Further, clinical research has provided evidence for neuroinflammation in subjects with major depression 11 or depressive symptoms comorbid to chronic pain. 12 Likewise, glial activation has been recently implicated in the pathophysiology of fibromyalgia 14 and Gulf War Illness, 16 both conditions characterized by several symptoms including excessive fatigue and "brain fog", which are symptoms reported by many during the pandemic. As such, preclinical and clinical work provide support the investigation of neuroinflammation as a mechanism of the symptoms observed with increasing frequency during the COVID-19 pandemic, -importantly-even among the non-infected.

TSPO is a five-transmembrane domain protein mostly expressed on the outer membrane of mitochondria which is dramatically overexpressed in activated microglia and astrocytes, as well as peripheral immune cells 18 in the context of neuroinflammatory responses. Indeed, a strong colocalization between TSPO upregulation and activated glial cells has been found across multiple preclinical and human studies of various disorders, including in rodent and human studies of multiple sclerosis, human immunodeficiency encephalitis, ischemia, depression, and Alzheimer's disease. 18, 22 While specificity of TSPO upregulation to glial cells is questioned in other work, the co-occurrence of post-lockdown elevations also in the brain concentration of mIns (a metabolite . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted September 27, 2021. ; https://doi.org/10.1101/2021.09.21.21263740 doi: medRxiv preprint that is more abundant in glial cells rather than other cell types) 19 as well as our imaging transcriptomics analyses (which map the TSPO signal increases to the the constitutive architecture of genes implicated in immune/neuroimmune signaling) corroborate a neuroinflammatory interpretation of our imaging findings. Interestingly, our results have shown that the mean thalamic levels of mIns and [ 11 C]PBR28 were not correlated, albeit we did previously observe an association between the two glial markers in patients with amyotrophic lateral sclerosis. 28 It is possible that changes in [ 11 C]PBR28 and mIns levels observed in our study may reflect distinct neuroinflammatory processes or two elements of a common process with different time courses (as previously suggested). 19 When interpreting the results of our study, the reader should be mindful of several limitations. First, HCPOST had a relatively small sample size, particularly compared to the HCPRE cohort (a limitation largely imposed by the COVID-19 pandemic-related disruption on clinical research) 29 . However, multiple factors provide high confidence in the solidity of our observations, including the consistency of our observations across individuals, scanners, age groups, genotypes, and sexes (see Appendix, Suppl. Figure 3) , the relative stability of the pre-lockdown markers, the observed elevation of two separate imaging markers measured using independent imaging modalities and the finding of significant enrichment in genes highly expressed in glial cells.

Second, our analysis was largely based on unpaired comparisons of pre-and post-lockdown groups. While our single subject scanned both pre-and post-lockdown demonstrated PET signal elevations in the same regions observed in the group comparison, longitudinal assessments of more individuals scanned in the same manner will be needed to better understand the impact of the COVID-19 pandemic on brain health.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 27, 2021. ; https://doi.org/10.1101/2021.09.21.21263740 doi: medRxiv preprint Third, because pandemic-specific questionnaires were not collected at the time of the scan visits, behavioral analyses were conducted using retrospectively collected questionnaire data, and only from a subset of subjects. As such the link between neuroinflammation and clinical symptoms presented in this report should be regarded as preliminary, and will need validation in larger studies.

Irrespective of these limitations, our study presents novel evidence of pandemic-related neuroinflammation in non-infected participants, providing an example of how broad the impact of the pandemic has been on human health, extending beyond the morbidity directly induced by the virus itself. As prolonged inflammation can be implicated in the pathogenesis of a variety of conditions, including breakdown of immune tolerance, 30 future studies are needed to assess the long-term implications of COVID-19-pandemic related neuroinflammatory responses.

LB conceived the idea for the study, conducted the main study design and validation, undertook the data analysis, wrote and revised the manuscript. ZA contributed to PET data collection, data pre-processing and manuscript revision. MK contributed to PET and clinical data collection, data analysis and manuscript revision. AW contributed to 1 H-MRS data collection and pre-processing, and manuscript content. HH contributed to data analysis and manuscript revision. EJM, PCK, KACB, OJA, NRZ and DSA contributed to data collection. EMR contributed to the study funding, data collection and manuscript revision. CET contributed to manuscript revision.

MV, FT and NH contributed to manuscript revision and data interpretation. DM performed the imaging transcriptomics analyses, contributed to data interpretation and manuscript content. BRR . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 27, 2021. ; https://doi.org/10.1101/2021.09.21.21263740 doi: medRxiv preprint contributed to data interpretation. The statistician (NDM) contributed to data analysis. JMH contributed to study funding. The corresponding author (MLL) contributed to study funding, data collection, supervised data analysis and data interpretation and contributed to writing the manuscript. All authors approved the manuscript and had final responsibility for the decision to submit for publication. LB and MLL had full access to and verified the underlying data. The study results were shared with all study team members through online presentations. All authors had the opportunity to contribute to the data interpretation and manuscript content through helpful discussions and written communications. All authors have read and approved the final manuscript.

All authors declare no competing interests.

Following publication of the study results, data will be made available upon reasonable request.

The Institutional Review Board (IRB) of Mass General Brigham (MGB) gave ethical approval to this study. Written informed consent was obtained from all participants before enrollment according to the ethical standards of the 1964 Helsinki declaration.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Areas of elevated PET [ 11 C]PBR28 signal (SUVR) in HCPOST subjects compared to HCPRE . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Displayed values are adjusted for scanner and age.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 27, 2021. ;

Indicators of anxiety or depression based on reported frequency of symptoms during the last 7 days. Household Pulse Survey. US Department of Health and Human Services, CDC, National Center for Health Statistics

Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science

Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic

LOVE in the time of Covid-19: a brief mental health intervention to overcome loneliness

The association between loneliness, social isolation and inflammation: a systematic review and meta-analysis

Microglial over-activation by social defeat stress contributes to anxiety-and depressive-like behaviors

Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness

Sickness and in Health: The Co-Regulation of Inflammation and Social Behavior

Cytokine, sickness behavior, and depression

Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders

Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study

The neuroinflammatory component of negative affect in patients with chronic pain

Neuroinflammation and depression: A review

Brain glial activation in fibromyalgia -A multi-site positron emission tomography investigation

Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study

In-vivo imaging of neuroinflammation in veterans with Gulf War illness

Sleep Inconsistency and Markers of Inflammation

Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain

Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis

An anatomically comprehensive atlas of the adult human brain transcriptome

The impact of the rs6971 polymorphism in TSPO for quantification and study design

Vivo Imaging of Human Neuroinflammation

Social stress induces neurovascular pathology promoting depression

Interleukin-1 receptor on hippocampal neurons drives social withdrawal and cognitive deficits after chronic social stress

Functional connectivity between the thalamus and the primary somatosensory cortex in major depressive disorder: a resting-state fMRI study

Inflammation: The Common Pathway of Stress-Related Diseases

Loneliness promotes inflammation during acute stress

Integrated imaging of [(11)C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy (1)H-MRS in amyotrophic lateral sclerosis

It is unprecedented: trial management during the COVID-19 pandemic and beyond

Chronic inflammation in the etiology of disease across the life span

The authors would like to thank Dr. Ciprian Catana and Dr. Julie Price for helpful discussion on data quality control, and Angel Torrado-Carvajal, Atreyi Saha, Courtney Bergan and Yang Lin for help with data collection. We also thank Grae Arabasz, Regan Butterfield and Shirley Hsu and all the A.A. Martinos Radiochemistry team for producing and administering the